Moolec Science (MLEC) Change in Cash (2022 - 2024)
Moolec Science (MLEC) reported Change in Cash of -$22.1 million for Q4 2024, down 41.17% on a YoY basis from -$37.6 million in Q1 2024, and down 1180.07% sequentially from -$1.7 million in Q3 2024.
Moolec Science (MLEC) Change in Cash (2022 - 2024) Analysis & Trends
Moolec Science (MLEC) has 3 years of Change in Cash data on file, last reported at -$22.1 million in Q4 2024.
- For the quarter ending Q4 2024, Change in Cash fell 41.17% year-over-year to -$22.1 million; the trailing twelve-month figure through Dec 2024 stood at -$12.3 million (up 28.79% YoY), and the FY2025 full-year result was -$47.4 million, down 544.19% from the prior year.
- Change in Cash eased to -$22.1 million in Q4 2024, from -$1.7 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $9.3 million in Q4 2022 to a low of -$22.1 million in Q4 2024.
- A 3-year average of -$1.6 million and a median of -$49631.0 in 2022 frame the typical range for Change in Cash.
- Peak annual rise in Change in Cash reached 4204.67% in 2023, while the deepest fall reached 17683.37% in 2023.
- Tracing MLEC's Change in Cash over 3 years: stood at $9.3 million in 2022, then tumbled by 267.77% to -$15.7 million in 2023, then tumbled by 41.17% to -$22.1 million in 2024.
- Business Quant data shows MLEC's Change in Cash at -$22.1 million in Q4 2024, -$1.7 million in Q3 2024, and $9.3 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Moolec Science | 5.21 Bn | 5.21 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -22.12 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | 9.28 Mn |
| Mar 31, 2024 | 2.29 Mn |
| Dec 31, 2023 | -15.67 Mn |
| Sep 30, 2023 | -1.70 Mn |
| Jun 30, 2023 | 4.47 Mn |
| Mar 31, 2023 | -4.35 Mn |
| Dec 31, 2022 | 9.34 Mn |
| Sep 30, 2022 | 9,648.00 |
| Jun 30, 2022 | -108,910.00 |
| Mar 31, 2022 | 1.06 Mn |